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Abstract-The bacterial strain Rhodococcus butmica (ATCC 21197), which exhibits nitrilase and nitrile hydratasekmidase 
activities, catalyses the enantioselective hydrolysis of racemic naproxen nitrile (R/S)-1 to furnish a moderate nantiomeric excess 
of (S)-naproxen (9-3. Racemic naproxen amide (R/S)-2 is not a good substrate for this strain. Resting cells of the newly selected 
bacterial strain Rho&coccus sp. C3II catalyse the enantioselective hydrolyses of racemic naproxen nitrile (R/S)-1 and naproxen 
amide (R/S)-2 as well, to give (S)-3 in excellent optical (99 % e.e.) and good chemical yields in aqueous medium and in the 
biphasic system of phosphate buffer/hexane. 
2Arylpropanoic acids constitute an important class of non- 
steroidal, anti-inflammatory compounds.3 Several 
substances of this class, such as naproxen, ibuprofen, 
ketoprofen, and fluorbiprofen, have been successfully 
introduced as chemotherapeutic agents. 
Although all of the above mentioned compounds possess a 
centre of asymmetry, only syntheses leading to their 
racemates were developed until recently.3 This situation has 
changed within the last few years. Before clinical approval 
of a new biologically active substance possessing a centre 
of chirahty can be obtained, the spectrum of action and 
metabolism of each individual enantiomer has to be 
demonstrated. If one stereoisomer should exhibit a 
markedly better activity than the other, it is advantageous 
to use only the more efficient stereoisomer in the 
commercial product. 
For this reason, numerous investigations have been carried 
out in the past few years with the objective of preparing 
the clinically most important examples of 2arylpropanoic 
acids in optically pure states. In a recent publication4 all 
the major stereoselective syntheses leading to single 
enantiomers of this class of compounds were summarized. 
However, these were mainly chemical syntheses; enzymatic 
methods were only mentioned briefly.4 
In the case of enzymatic methods it is obvious that the 
resolution of racemic 2arylpropanoic acids could be 
achieved by enantioselective hydrolysis of the esters or by 
enantioselective esterification of the carboxylic acids using 
esterases or lipases, respectively.5 A further possibility for 
the preparation of optically active a-arylpropionic acids by 
way of an enzyme-catalysed reaction is the enantioselective 
hydrolysis of the corresponding racemic nitriles. This is the 
subject of the present paper. 
The use of enzymes or resting cells, respectively, for the 
preparation of carboxylic acid amides or carboxylic acids 
from the corresponding nitriles has been described by H. 
Yamada et al. as well as by other groups.6 The hydrolysis 
of acrylonitrile to acrylamide by resting cells of 
Pseudomonas chlororaphis B23, for example, has been 
developed into a large-scale industrial process.6aFb 
The nitrile hydrolysis can take place either directly to 
furnish the carboxylic acid by means of a nitrilase (EC 
3.5.5.1) or as a two-step reaction by means of a nitrile 
hydratase to give the carboxylic amide and then by means 
of an amidase (EC 3.5.1.4) to yield the carboxylic acid.7a 
R-CN ____t R-COW + NH, 
Figure 1. General mechanism of the enantioselective microbial 
hydrolysis of nitriles to carboxylic acids. 
The hydrolysis of amides using amidases from bacterial 
strains of various genera was described by P. Galzy et al.8 
The enantioselective hydrolysis of racemic nitriles by 
means of an enzyme was reported by H. Ohta et a1.9 Since 
then some further papers and patents on the 
enantioselective hydrolyses of racer& nitriles by nitrilases 
or nitrile hydratases and amidases have appeared. Thus, a- 
aminonitriles have been hydrolysed to optically active 
amino acids by a nitrilase from Rhodococcus rhodochrous 
PA-34.1° Similarly, O-protected cyanohydrins have been 
enantioselectively h drolysed to the corresponding optically 
active a-hydroxycarboxylic acids by Rhodococcus 
butanicalla and by resting cells of Pseudomonas 
specie~.~~~ Much attention has been directed recently to the 
preparation of optically active a-arylpropionic acids from 
the corresponding nitriles by enantioselective hydrolyses 
using nitrile-hydrolysing enzymes.g~12~13 Such enzymes 
have been found in plants, fungi, bacteria, sponges, algae, 
and insects.7 
Our investigations concentrated mainly on the preparation 
of (S)-(+)-naproxen since only the Wenantiomer is used 
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in therapy and since it is one of the most commercially 
important members of this class of compounds. 
Hydrolysis of a-Arylpropionic Acids by 
Rhodococcus butanica 
ATCC 21197 
Ohta et al. have described a strain of R. buranicu, ATCC 
21197, that hydrolyses a-arylpropionitriles to the 
corresponding carboxylic acids with a very high 
enantioselectivity.g This strain exhibits nitrilase, nitrile 
hydratase, and amidase activities. The nitrilase 
preferentially hydrolyses the (S)-nitrile to give the (Q-acid. 
The stepwise conversion of racemic nitriles includes the 
preferential formation of the (R)-enantiomer by the nitrile 
hydratase and faster hydrolysis of Q-amides by the amidase 
to give (R)-amides in high optical purities.g 
Starting with cells obtained from the American ATCC 
collection (No. 21197), we achieved normal growth but the 
cells obtained did not exhibit any nitrile-hydrolysing 
activity. Only after H. Ohta14 had kindly provided us with 
a sample of cells of the strain used in his work did we 
obtain cells which were indeed able to catalyse nitrile 
hydrolysis. Our results on the enantioselective nitrile 
hydrolysis are compared with the findings of H. Ohta in 
Table 1. 
Table 1. Enantioselective hydrolysis of racemic a-arylpropio- 
nitriles to (S)-a-arylpropionic acids by Rhodococcus butanica in 
phosphate buffer (pH 8.0, 100 mIvQ2,’ 
R!a.ctiml (&icid 
nbmale time Yield 03 
R= [hl WI WI 
Gill 3 4 70 
8 16 78 
24 s1 26 
cl 8 15 96 
24 33 41 
cm a 46 99 
24 54 88 
EaolGbyOtltm8lLJ 
A?actim 0-M 
he Y&ld k 
N PI WI 
3 6 75 
6 13 87 
24 60 I5 
6 13 r99 
24 30 43 
6 47 99 
24 59 53 1 
From the results summarized in Table 1, it can be 
concluded that only in the case of 2-(p - 
methoxyphenyl)propionitrile (R = CH30) a high optical 
yield (99 % e.e.> was obtained in combination with a good 
chemical yield (47 % conversion). However, the 
enantioselectivity in the case of the important drug 
ibuprofen (R = i-Bu) is appreciably lower. Even at low 
conversion (13 %) an e.@. value of only 87 % was obtained 
(Table 1). Experiments on the enantioselective hydrolysis 
of racemic naproxen itrile were not reported by Ohtag 
On the basis of our experience with 2-phenylpropionitriles 
(Table l), we have investigated the enantioselective 
hydrolysis of racemic naproxen nitrile (R/S)-1 and 
naproxen amide (R/S)-2 with resting cells of R. butanica 
ATCC 21197 under various conditions. 
Scheme I illustrates the two possible pathways for the 
enantioselective hydrolysis of racemic naproxen nitrile 
(R/S)-1 to optically active naproxen W-3 under catalysis 
by R. butanica. 
2 
Scheme I. Enantiosclective hydrolysis of racemic naproxen nitrile 
(R/S)-1 to (S)-naproxen (S)-3 catalysed by Rhodococcus butanica . 
The racemic substrates naproxen nitrile (R/S)-1 and 
naproxen amide (R/S)-2 were prepared as described in the 
literature.15 Racemic naproxen (R/S)-3 can be obtained by 
hydrolysis of (R/S)-1 with KOH in ethano1.15a*16 
Optically pure amide Q-2 was prepared from Q-naproxen 
via the acid chloride and subsequent reaction with aqueous 
ammonia The formation of (S)-naproxen was monitored 
directly by HPLC and the naproxen enantiomers were 
separated on a chiral phase with the enantiomeric excess 
calculated by evaluation of the peak areas. 
Naproxen nitrile (R/S)-1 is a good substrate for R. 
butunicu. The results of the conversions at two different 
substrate concentrations are summarized inTable 2. 
Table 2. Enantioselective hydrolysis of racemic naproxeo nitrile 
(R/s)-1 to naproxen (n-3 and naproxen amide 2 catalysed by resting 
cells of Rhodococcus butanica in phosphate buffer 
A B 
(St-3 2 RcacLion @3 
time Da] Yii [%I m ($61 Ykld [WI tiaw @I Yield [%I cc [%J 
3 15 97 5 4 18 98 
6 39 86 a 19 31 87 
24 59 51 II 24 34 a5 
A: Resting cells (OD 4.8); (R/S)-1: 8.5 mg (0.040 mmol). 
B: Resting cells (OD 60); (R/S)-1 : 90.0 mg (0.43 mmol). 
At the concentrations we used, the enantiomers of naproxen 
amide (2) were incompletely separated by HPLC on a 
human serum albumin (HSA) column; thus only the 
chemical yields are given in Table 2. The configuration of 
the enantiomer of naproxen amide obtained was elucidated 
by co-chromatography with the enantiopure (S)-amide (S)- 
2. 
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We have also investigated the reactions of (R/S)-1 with 
i~ob~i~ cells of R burtutica. Cell i~obili~tion can, 
on the one hand, facilitate work-up of the reaction mixtures 
to simple devotion or filtration and, on the other hand, 
often has an advantageous effect on the maintenance of 
enzyme activity;17avb the latter aspect is of particular 
relevance in the case of long reaction times. Furthermore, 
cluing of the cells in the organic solvent is prevented 
aud the cells are better protected against damage by organic 
solvents.‘8 Of the investigated immobilization matrices, 
(e.g. alginate, silica gel, and polyurethane) which have 
previously been used for the immobilization of 
Rhodocmcus species,17 we found polyurethane PU31q 
(molwt 2529 glmol, 4.2 % NC0 and 57 8 ethylene 
oxide) to be the most suitable. In comparison to the results 
with non-immobilized cells, however, both the chemical 
and the optical yields were appreciably lower (see 
Experimental Section). 
Naproxen nitrile (R/S)-1 is only slightly soluble in 
aqueous media, so we also studied the reaction in biphasic 
systems composed of a phosphate buffer and an immiscible 
organic solvent. In this system the substrate (R/S)-1 is 
dissolved in the organic phase. The product acid (S)-3 is 
found exclusively in the aqueous phase, whereas the 
remaining nitrile (R)-1 is dissolved in the organic solvent, 
Hexane was found to be the best for the enz~e~a~y~ 
hy~lysis of (R/S)-1 in a biphasic system (Table 3). 
Table 3. FXnantioselective hydrolysis of racemic naproxen nitrite 
(R/s)-1 to naproxen (S)-3 catalysed by Rhodococcus butattica in the 
bipbasic system phosphate buffer/heme 
A: Non-immobilized cells (OD 61); (R/S)-1 : 90.0 mg (0.43 mtnol). 
B: Cells immobilized on PU3 (OD 61); (R/S)-1: 90.0 mg (0.43 
mmol). 
When non-i~obilized cells are used, the results in 
aqueous media and in the biphasic system are comp~~le 
(Tables 2 and 3). However, with i~obilized cells, the 
reactions proceed more slowly and give poorer optical 
yields (Table 3). 
Since the hydrolysis of (R/S)-1 by R. butanica is catalysed 
not only by the nitrilase activity but also by the nitrile 
hydratase and amidase activities, the amide (R/S)-2 should 
also be, and indeed is, a suitable substrate. The hydrolyses 
of the two substrates (R/S)-1 and (R/S)-2 at equimolar 
concentrations are compared in Table 4. 
Poorer chemical and optical yields were obtained with the 
racemic amide (R/S)-2 than with the nitrile (R/S)-1; this 
can readily be explained in terms of the three-enzyme 
system of R. butunica. Both routes (see Scheme I) catalyse 
the hydrolysis of (R/S)-1 to the acid (S)-3. Since the 
Table 4. Comparison of the enantioselective hydroiysis of raccmic 
naproxen nitrile (R/s)-1 and racemic naproxen amide (R/S)-2 to 
naproxen (Q-3 catatysed by ~~o~ococcus buranica in phosphate 
buffer 
1.5 22 97 1.5 IS 91 
3 30 94 3 20 81 
6 33 87 6 25 70 
Resting cells (OD 80); (R/S)-1: 90.0 mg (0.43 mmol), (R/s)-2: 97.7 
mg (0.43 mmo1). 
chemical yields of the reaction with naproxen nitrile as 
substrate are higher than those using naproxen amide as the 
only substrate and since higher optical yields occur during 
the hydrolysis of the nitrile (R&)-l, we conclude that the 
nitrilase exhibits a higher enantioselectivity than the 
amidase. 
In addition to naproxen amide (R/5)-2, methylbenzyl 
cyanide was also used as a substrate for R. butmica. 
However, it is not a good substrate since e.e. values of 96 
% were only obtained at very low conversions (4 %), at 
conversions of 8 % the e.e. value decrease to 77 %. 
EnantioselectIve Hydrolysis of Racemlc 
Naproxen Nitrile (R/S)-1 by Rhoducoccus p. 
C3II 
The strain C311, isolated and developed by N. Layh?ua 
most probably belongs to a yet u&scribed species in the 
genus Rhod~coccus. The isolation, enrichment, and 
characterization f this new strain have been described in a 
previous publicationm The excellent catalytic properties 
of the strain C311 in the enantioselective hydrolysis of 
naproxen itrile (R,S)-1 and naproxen amide (R/S)-2 were 
reported in the same paper.% 
In the present paper, emphasis i  placed on the preparative 
aspects of the application of Rhudococcus sp. C311 for the 
preparation of (S)-naproxen (S)-3 from racemic naproxen 
nitrile (R/S)-1 or naproxen amide (R/&2. R. sp. C3II 
exhibits only nitrile hydratase and amidase activities but no 
nitrilase activity. Both enzymes are ~onstitutive20b and 
both prefer the (S)enantiomer.20b 
In order to obtain comparable r sults, the experiments were 
performed analogously to those with R. butmica. As 
mentioned above, polyurethane PU3 also proved to be 
particularly suitable for the immobilization of 
R~od~coccus sp. C311. At reaction times of l-3 h, e.6. 
values of 99 % were achieved with chemical yields of 27- 
49 %. The results obtained with small amounts of 
substrate can also be achieved with larger amounts (Table 
5). 
With regard to the optical yields, no differences were 
observed between immobilized and non-immobilized cells 
whereas the chemical yields were appreciably lower in the 
former case (Table 5). 
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Table 5. Enantioselective hydrolysis of racemic naproxen nitrile 
(R/S)-1 to naproxen (Q-3 cataiysed by resting cells of R~o~~c~~ 
sp. C3iI in phosphate buffer 
r I , I 
A: Cells immobilized on PU3 (OD 1.6); (R&&l: 4.2 mg (0.02 mmoi). 
B: Ceifs irn~bitiz~ on PU3 (OD 37); (R/S)-1: 90.0 mg (0.43 
llIIll01). 
C: Non-immobilized cells (OD 37); (R&)-l : 90.0 mg (0.43 mmoi}. 
The concentration dependence, which can be recognized 
from the substrate/product distribution, in the hydrolysis of 
nitriles with Rhodococcus p. C311 is of interest. At lower 
concen~tions (0.2 mM) 41 % (R)-2 (95 % e-e..) and 40 % 
(S)-3 (>99 % e.e.) are formed while at higher 
concentrations (14.2 mM) 4 % (S)-2 and 38 % (5’)~3 (99 % 
e.e.) are obtained. This indicates that the nitrile hydratase 
functions more rapidly than the amidase at the lower 
concentration20b and that the nitrile hydra&se is apparently 
i~bi~ at the higher concen~ation. 
The biphasic system comprising phosphate buffer/hexane 
was also employed for the enantioselective hydrolysis of 
(R/S)-1 by resting cells of Rhodococcus sp. C311. 
Enantiomeric excesses of >99 8 and good chemical yields 
were realized at low substrate concen~ations with 
m~nten~ce of enzyme activity; after a reaction time of 5 h 
in the biphasic system, the enzyme shows, in pure 
phosphate buffer, a complete intact activity giving 43 % 
chemical and 99 % optical yields of (Q-3. Thus, higher 
substrate concentrations may also be employed under these 
conditions (Table 6). 
Table 6. Enantioseiective hy~~ysis of racemic naproxen nitrife 
(R/S)-1 to naproxen (s)_3 catalyscd by Rhodococcus sp. C3II in the 
biphasic system phosphate buffer/heme 
A: N~-i~obi~z~ cells (Of) 38); (R/S)-1 : 90.0 mg (0.43 mmol). 
B: Cells i~obiIi~ on PU3 (OD 38); (R/S}-1: 90.0 mg (0.43 
mmol). 
In the course of these experiments it was found that (R/s)- 
1 is only moderately soluble in hexane with 8 maximal 
solubility of 4.185 g/L. Accordingly, and also for the 
purpose of comp~bili~ with the reactions of R. b~t~ni~o, 
0.43 mm01 of substrate were employed. Excellent e.e. 
values (approximately 99 %) were obtained with both 
immobilized and non-immobilized resting cells. However, 
the chemical yields differed since the reaction with non- 
immobilized cells-like that in pure aqueous medium- 
proceeds more rapidly. The conversion rate in pure 
phosphate buffer is four times higher than in the biphasic 
system. Since comparable optical and chemical yields are 
obtained in phosphate buffer, the biphasic system does not 
offer any advantages. In comparison to R. butunica (Table 
3), markedly better enantiomeric excesses of (5)-3 at 
comparable chemical yields were obtained with 
R~dococcMs p, C311. 
Experiments with solubilizers such as DMSO, Tween 80, 
or Triton X100, which are reputed to increase the solubility 
of naproxen nitrile in water, were unsuccessful. The 
enzyme activity decreased even upon addition of the 
smallest amounts of solubilizing agent. 
In analogy to the experiments with R. butunicu (Table 4), 
the amide (R/S)-2 was also used as a substrate for 
Rhodococcus sp. C311 (Table 7). 
Table 7. Comparison of the enantioselective hydrolysis of racemic 
naprvxen nitrile (R/$)-l and racemic naproxen amide (R/S)-2 to 
naproxen (S)-3 catalysed by Rhodococcus sp. C3Il in phosphate buffer 
Resting celfs (OD 37); (R/@-l: 90.0 mg (0.43 mmolf, (R&)-2: 97.7 
mg (0.43 mmoll. 
Together with excellent @.&. values of approximately 99 8, 
somewhat better chemical yields, in comparison to the 
substrate (R/S)-1 (Table B), were realized. Thus, in contrast 
to R. but~nic~, tie amide (R/S)-2 is an excellent substrate 
for R~doco~c~ sp. C31I. 
Encouraged by these good results, we employed higher 
substrate concentmtions of (R/s)-1 in order to evaluate the 
preparative utility of Rhodococcrar sp. C311 (Table 8). 
Table 8. Determh~&on of the co~en~ti~ maximum of racemic 
naproxen nitrite (R/S)-1 in the enantioselective hydrolysis to 
naproxen (S)-3 catalyscd by Rhodococcus sp. C3II in phosphate buffer 
@w-l Reaction Q-3 
mglsomlbufftr thcilQ Yicdd[%l et-@] 
200 2 31 >99 
65 41 >99 
a1 49 93 
300 4 5 >99 
24 20 299 
48 23 r99 
400 4 3 >99 
24 8 >99 
48 9 99 
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As can be seen from Table 8, e.e. values of 99 % were 
obtained for all three concentrations (2~ mg) of 
substrate (R/S)-1 in phosphate buffer. In contrast, the 
chemical yield decreased markedly with increasing amounts 
of substrate. Thus, with 200 mg of substrate after 6.5 h the 
conversion rate is 25.23 mg/h/g cells (dry weight) while, 
with 300 mg of substrate, the conversion rate after 24 h is 
only 5.00 mg~g cells (dry weight). Thus, the chemical 
yield of (Q-3 only increases from 20 to 23 % between 24 
and 48 h reaction time. With 400 mg of substrate this 
effect is even more obvious and the conversion rate is only 
2.67 mg/h/g cells (dry weight) after 24 h reaction time. 
reaction mixture was neutralized with dilute HCl. The 
phases were separated and the aqueous phase was extracted 
twice with ~chIoro~~~e_ The combined extracts were 
dried with MgS04 and concentrated. The residue was 
~h~~to~ap~d on silica gel with petroleum e~er/e~yl 
acetate (1:l) to give 67 mg (59 %) (S)-2. ‘H NMR data 
identical with those of (R/S)-2 
Naproxen (RB)3 
Prepared according to Ref. 16a. 
The limiting factor in all the reactions described apparently 
is the ratio of substrate to cell amount. Since the optical 
density of 1.0 corresponds to 220 mg of bacterial dry 
weight per litre of culture,20b about 0.5 g of cells are 
present in the described experiments (Table 8). Hence a 
guiding value for the maximum of substrate/cell ratio can 
be derived as follows: 0.5 g of substrate (R&)-l per 1 g of 
dry weight of cells. 
Media, isolation and characterization ofRhodococcus p. 
c3zz 
See Ref. 20b. 
Immobilization of cells 
Experimental Section 
PU3 prepolymer (0.5 g) was melted (30-35 “C) and after 
cooling to 20-25 ‘C cells suspended in 1 mL phosphate 
buffer (50 mM, pH 7.4) were added and the mixture was 
stirred for 30 s. The mixture was cooled to 4 “C for 1 h and 
then the polymer was cut into pieces of 3-6 mm3. 
Materiah and methuds Conversions with resting cells in aqueous medium 
‘H NMR: Bruker AC 250 F, TMS as internal standard. 
Optical density (GD): Uvikon 810 P S~~ophoto~~ 
(Kontron). HPLC: Pharmacia LKB system, Chiral AGP- 
column (100 x 4 mm) aud HSA-column (100 x 4 mm, 5 
pm silica gel particles with human serum ~bu~n) from 
Chrom Tech, Norsborg, Sweden. PU3 prepolymer was 
provided from Toyo Rubber Ind. Co., Osaka, Japan. (S)- 
Naproxen was purchased from Sigma and Millex-GS sterile 
falter (22 l.tm) from Millipote. All solvents were purified as 
described in the literature. 
Cells were suspended in 30 mL (R~dococc~ sp. C31D or 
50 mL (R. butunicu) phosphate buffer (50 mM, pH 7.4), 
the optical density was measured (see Tables 2,4,5 and 7) 
and the substrate (R/S)-1 f90.0 mg (0.43 mmol)] or (R/S)- 
2 197.7 mg (0.43 mmol)] was added at 30 “C to the stirred 
(250 rpm) solution. At the given times (see Tables 2,4,5 
and 7) 1 mL of the medium was taken through a sterile 
filter and was analyzed by HPLC. 
Comparison of conversions with immobilized or non- 
immobilized cells of Rhodococcus butanica 
Naproxen itrile (R/s)-3 
Prepared according to Ref. 15a,b. 
Naproxen amide (R/S)-2 
Conversions of resting cells, immobilized on PU3 (OD 60) 
or non-immobilized (OD 60), were carried out as described 
above in 50 mL phosphate buffer (50 mM, pH 7.4) with 
0.43 mm01 of (R/S)-1. 
Prepared according to Ref.l&, from 1.06 g (5.0 mmol) 
naproxen nitrile, 10 mL tett-butyl alcohol, 1 g finely 
powdered potassium hydroxide, chromatography on silica 
gel with petroleum ether/ethyl acetate (l:l), yield 0.8 g (70 
%) naproxen amide, mp 158-159 “C; “H NMR (CD(&): 6 
= 1.39 (d, J = ‘7.1 Hz, 3H, CH3), 3.70 (q, J = 7.1 Hz, lH, 
CH), 3.86 (s, 3H, CH:,O), 7.11-7.79 (m, 6H, 
naphthalene). 
Table 9. Hydrolysis of rwemic naproxen nitrile (R/s)-1 to (8) 
naproxen (n-3 catalywd by immobilized (A) or non-immobilized 
cells (B) of Rhodocwcus bscranicn 
ASP-Nup~xen amide (9-2 
(S)-3, 115 mg (0.5 mmol) dissolved at 0 “C in 2 mL 
thionyl chloride, was refluxed for 1 h. The excess of 
thionyl chloride was removed under reduced pressure. The 
residue was taken up in 5 mL dichloromethane, 
concentrated, issolved again in 5 mL dichloromethane and 
cooled to 0 “C. With vigorous stirring 5 mL of cont. 
ammonia were slowly dropped and with cooling the 
Conversions with resting cells in a biphasic system 
Resting cells, suspended in 30 mL (Rhodococcus p. C3I1, 
optical density of 38) or 50 mL (R. bratanica, optical 
density of 61) phosphate buffer (50 mM, pH 7.4), were 
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mixed with 20 mL n-hexane. The substrate (R/S)-1 (90.0 
mg (0.43 mmol) dissolved in 0.5 mL methanol) was then 
added to the stirred (600 rpm) cell suspension. At the given 
times (see Tables 3 and 6) 1 mL of the medium was taken 
and was analyzed by HPLC. 
Determination of the concentration maximum of (R/s)-1 
in the hydrolysis catalysed by Rhodococcus p. C3II 
Conversions were carried out as described above in 50 mL 
phosphate buffer (50 mM, pH 7.4) with resting cells 
(optical density of 46) and various amounts of (R/S)-1 
[ 100.0-400.0 mg (0.47-1.90 mmol) as concentrated 
metbanolic solutions 1. 
Analytical methods 
The formation of naproxen (3) was analyzed by HPLC. For 
separation of the enantiomers of aaproxen (3) a Chiral 
AGP-column (with guard column) with phosphate buffer 
(10 mM, pH 7.0) as solvent was used [flow rate 0.6 
mL/miu, Rt (R)-naproxen = 3.5 min, Rt (S)-naproxen = 
5.7 min] at a detection wavelength of h = 230 nm. For 
separation of the enantiomers of naproxen amide (2) a 
HSA-column (with guard column) with phosphate buffer 
(100 mM, pH 7.0) as solvent was used [flow rate 0.6 
mL/min]. The enantiomeric excess (e.e.) of (S)-naproxen 
(S)-3 was calculated by comparison of the peak areas 
obtained by HPLC analyses. The identity of (S)-naproxen 
(S)-3 was determined by co-chromatography with an 
enantiopure standard. 
Growth measurement 
Growth of bacterial cultures was monitored 
spectrophotometrically by measuring the optical density at 
h = 546 nm. For the measurements, the cell suspensions 
were diluted with phosphate buffer (50 mM, pH 7.4) either 
1:9 or 120. The optical density of 1.0 corresponded to 220 
mg of bacterial dry weight per liter of culture.20b 
Acknowledgements 
We thank M. Layh and Professor H.-J. Knackmuss for the 
isolation and characterization of the bacteria strain 
Rhodococcus sp. C311 and the Bundesministerium fi.ir 
Forschung und Technologie (BMFT) for financial support 
of this work. 
References and Notes 
1. Enzyme-Catalyzed Reactions, Part Il.-Part 17: Barth, S.; 
Effenberger, F. Tetrahedron: Asymmetry 1993,4, 823. 
2. BBhme, J. Dissertation, Univ. Stuttgart, 1993. 
3. a) Shen, T. Y. Angew. Chem. Int. Ed. Engl. 1972, II, 460; 
b) Giordano, C.; Castaldi, G.; Uggeri, F. Angew. Chem Znt. 
Ed. Engl. 1984, 23, 413; c) Rieu, J. P.; Boucherle, A.; 
Cousse, H.; Mouzin, G. Tetrahedron 1986,42, 4095. 
4. Sonawane, H. R.; Bellur, N. S.; Ahuja, J. R.; Kulkarni. D. G. 
Tetrahedron: Asymmetry 1992.3, 163. 
5. a) Gu, Q.-M.; Chen, C.-S.; Sih, C. J. Tetrahedron Lett. 
1986, 27, 1763; b) Ahmar, M.; Girard, C.; Bloch, R. 
Tetrahedron Lett. 1989,30, 7053; c) Zhang, X.-M.; Wainer, 
I. W. Tetrahedron Lett. 1993,34, 4731; d) Mutsaers, J. H. G. 
M.; Kooreman, H. J. Reel. Trav. Chim. Pays-Bas 1991,110, 
185; e) Battistel, E.; Bianchi, D.; Cesti, P.; Pina, C. 
Biotechnol. Bioeng. 1991.38, 659; f) Senanayake, C. H.; 
Bill, T. J.: Larsen, R. D.; Leazer, J.; Reider, P. J. Tetrahedron 
Lett. 1992,33, 5901. 
6. a) Nagasawa, T.; Yamada, H. Pure Appl. Chem. 1990,62, 
1441; b) Nagasawa, T.; Yamada, H. Biocatalysis, pp. 277- 
318, Abramowicz, D. A., Ed: Van Nostrand, R.; New York, 
1990; c) Thompson, L. A.; Knowles, C. J.; Linton, E. A.; 
Wyatt, J. M. Chem. Br. 1988, 900: d) HBnicke-Schmidt, P.; 
Schneider, M. P. J. Chem. Sot., Chem Commun. 1990, 648; 
e) Cohen, M. A.; Sawden, J.; Turner, N. J. Tetrahedron Lett. 
1990,31, 7223; f) De Raadt, A.; Klempier, N.; Faber, K.; 
Griengl. H. J. Chem. Sot. Perkin Trans 1 1992, 137. 
7. a) Faber, K. Biotransformations in Organic Chemistry, 
Springer Verlag; Heidelberg, 1992; b) Yamada, H.; Shimizu, S. 
Angew. Chem. Znt. Ed. Engl. 1988,27. 622. 
8. a) Arnaud, A.; Galzy, P.; Jallageas, J.-C. C. R. Hebd. 
Seances Acad. Sci., Ser. D 1976, 283. 571; b) Jallageas, J.- 
C.; Amaud, A.; Galzy, P. C. R. Hebd. Seances Acad. Sci., Ser. 
D 1979, 288, 655; c) Amaud, A.; Galzy, P.; Jallageas, J.-C. 
Bull. Sot. Chim. Fr. 1980,2, 87; d) Jallageas, J.-C.; Arnaud, 
A.; Galzy, P. Adv. Biochem. Engin. 1980, 14. 1. 
9. Kakeya, H.; Sakai, N.; Sugai, T.; Ohta, H. Tetrahedron Lett. 
1991, 32, 1343. 
10. a) Macadam, A. M.; Knowles, C. J. Biotechnol. Lett. 
1985, 7, 865; b) Bhalla, T. C.; Miura, A.; Wakamoto, A.; 
Ohba, Y.; Furuhashi, K. Appl. Microbial. Biotechnol 1992, 
37, 184. 
11. a) Kakeya, H.; Sakai, N.; Sugai, T.; Ohta, H. Agric. Biol. 
Chem. 1991,.55, 1877; b) Layh, N.; Stolz, A.; FBrster, S.; 
Effenberger, F.; Knackmuss, H.-J. Arch. Microbial. 1992, 
158, 405; c) Endo, T.; Tamura, K. (Nitto Chemical Industry 
Co., Ltd) Eur. Pat. Appl. EP 449,648, 2 Ott 1991; Chem. 
Abstr. 1992, 116, 5338q. 
12. a) Yamamoto, K.; Ueno, Y.; Otsubo, K.; Kawakami, K.; 
Komatsu, K. Appl. Environ. Microbial. 1990,56, 3125; b) 
Yamamoto, K.; Otsubo, K.; Oishi, K. (Asahi Chemical 
Industry Co., Ltd) Eur. Pat. Appl. EP 348,901, 3 Jan 1990; 
Chem. Abstr. 1990. lZ3, 76605~; c) Yamamoto, K.; Otsubo, 
K.; Ueno, Y. (Asahi Chemical Industry Co., Ltd) Jpn Kokai 
Tokkyo Koho JP 03,224,496, 3 Ott 1991; Chem. Abstr. 
1992,116, 57584m; d) Cerbelaud, E.; Petre, D. (Rhone- 
Poulenc Sante) US 5,089,405, 26 Jul 1989; Chem. Abstr. 
1990,112, 196679b. 
13. Cohen, M. A.; Paratt, J. S.; Turner, N. J. Tetrahedron: 
Asymmetry 1992,3, 1543. 
14. We thank Professor H. Ohta very much for the provision of 
his strain Rhodococcus butanica. 
15. a) Arsenijevic, L.; Arsenijevic, V.; Horeau, A.; Jacques, J. 
Org. Synth. 1973,53, 5; b) Hiyama, T.; Inoue, M.; Saito, K. 
Synthesis 1986, 645; c) Hall, J. H.; Gisler, M. J. Org. Chem. 
1976,41, 3769; d) Takano, S.; Ogasawara, K.; Yanase, M. 
(Nisshin Flour Milling Co., Ltd) Jpn Kokai Tokkyo Koho JP 
02,311,442, 27 Dee 1990; Chem. Abstr. 1991, 114, 
206785r. 
16. a) Hiyama, T.: Inoue, M. Synthesis 1986, 689; b) 
Radhakrishna, A. S.; Bakthavatchalam, R.; Rao, K. R. K.; 
Singh, B. B. Org. Prep. Proceed. Znt. 1989, 21, 375; c) 
Hydrolysis of racemic naproxen itrile 721 
Nugent, W. A.; McKinney, R. J. J. Org. Chem 1985.50, 
5370; d) Harusawa, S.; Nakamura, S.; Yagi, S.; Kurihara, T.; 
Hamada, Y.; Shioiri, T. Synth. Commun. 1984.14, 1365. 
17. a) Omata, T.; Iida, T.; Tanaka, A.; Fukui, S. Eur. .I. Appi. 
Microbial. Biotechnol. 1979 8, 143; b) Omata, T.; Iwamoto, 
N.; Kimura, T.; Tanaka, A.; Fukui, S. Eur. J. AppL Microbial. 
Biotechnol, 1981,11, 199; c) Wingard, L. B.; Roach, R. P.; 
Miyawaki, 0.; Egler, K. A.; Klinzing, G. E.; Silver, R. S.; 
Brackin, J. S. Enzyme Microb. Technol. 1985, 7, 503; d) 
Martinez-Madrid, C.; Manjon, A; Iborra, J. L. Biotechnol. 
Lett. 1989,11, 653; e) Ahmad, S.; Johri, B. N. Appl. 
Microbial. Biotechnol. 1992, 37, 468. 
18. Brink, L. E. S.; Tramper, J. Biotechnof. Bioeng. 1985, 
27, 1258. 
19. We thank the Toyo Rubber Ind. Co., Osaka, for the 
provision of polyurethane prepolymers. 
20. a) Layh, N. Dissertation, Univ. Stuttgart, in preparation; 
b) Layh, N.; Stolz, A.; Biihme, J.; Effenberger, F.; 
Knackmuss, H.-J. J. Biotechnol. 1994.33, 175. 
(Received 31 May 1994) 
